GI
GBT

GAMCO Investors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

GAMCO Investors’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-46,544
Closed -$3.17M – 945
2022
Q3 		$3.17M Buy
+46,544
New +$2.57M 0.04% 389

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GAMCO Investors's GBT Position: Q4 2022 in Review

GAMCO Investors sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 46,544 shares — an estimated $3.17M sold.

GAMCO Investors first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $3.17M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • GAMCO Investors reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • GAMCO Investors sold 46,544 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $3.17M.
  • GAMCO Investors first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • GAMCO Investors's Global Blood Therapeutics, Inc. position peaked at $3.17M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on GAMCO Investors's 13F filing for Q4 2022, filed 13 Feb 2023.